A Multi-center, Post-Marketing Observational Study to Identify the Recovery Time in Patients With Upper or Lower Respiratory Tract Infections Treated With Klacid MR.
Phase of Trial: Phase IV
Latest Information Update: 28 Jun 2010
At a glance
- Drugs Clarithromycin (Primary)
- Indications Bacterial infections; Respiratory tract infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 28 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jun 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 03 Mar 2010 New trial record